
AI Drug Discovery Pioneer InSilico Medicine Launches Hong Kong IPO, With Backing From Lilly, Tencent
AI biotech firm InSilico Medicine is launching a major Hong Kong IPO, backed by cornerstone investments from Eli Lilly and Tencent, among others.
Showing 1 of 1 posts with this tag

AI biotech firm InSilico Medicine is launching a major Hong Kong IPO, backed by cornerstone investments from Eli Lilly and Tencent, among others.